These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17607425)

  • 1. Attention impairment associated with relapsing-remitting multiple sclerosis patients with mild incapacity.
    Balsimelli S; Mendes MF; Bertolucci PH; Tilbery CP
    Arq Neuropsiquiatr; 2007 Jun; 65(2A):262-7. PubMed ID: 17607425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.
    Edgar C; Jongen PJ; Sanders E; Sindic C; Goffette S; Dupuis M; Jacquerye P; Guillaume D; Reznik R; Wesnes K
    BMC Neurol; 2011 Jun; 11():68. PubMed ID: 21649910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different cognitive profiles of Brazilian patients with relapsing-remitting and primary progressive multiple sclerosis.
    Rodrigues DN; Paes RA; Vasconcelos CC; Landeira-Fernandez J; Alvarenga MP
    Arq Neuropsiquiatr; 2011 Aug; 69(4):590-5. PubMed ID: 21877025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
    Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T
    Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
    Papathanasiou A; Messinis L; Zampakis P; Panagiotakis G; Gourzis P; Georgiou V; Papathanasopoulos P
    J Neurol Sci; 2015 Nov; 358(1-2):236-42. PubMed ID: 26359854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis.
    Deloire MS; Salort E; Bonnet M; Arimone Y; Boudineau M; Amieva H; Barroso B; Ouallet JC; Pachai C; Galliaud E; Petry KG; Dousset V; Fabrigoule C; Brochet B
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):519-26. PubMed ID: 15774439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
    J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Information processing speed and influential factors in multiple sclerosis].
    Zhang ML; Xu EH; Dong HQ; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis.
    Kraemer M; Herold M; Uekermann J; Kis B; Daum I; Wiltfang J; Berlit P; Diehl RR; Abdel-Hamid M
    J Neuropsychol; 2013 Mar; 7(1):91-106. PubMed ID: 23126275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of neuropsychological impairment in the early phase of relapsing-remitting multiple sclerosis.
    Olivares T; Nieto A; Sánchez MP; Wollmann T; Hernández MA; Barroso J
    Mult Scler; 2005 Apr; 11(2):191-7. PubMed ID: 15794394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
    Hegedüs K; Kárpáti J; Iljicsov A; Simó M
    Mult Scler Relat Disord; 2019 Oct; 35():150-155. PubMed ID: 31376686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of interleukin-17A, tumor necrosis factor-alpha, interleukin-18, interleukin-10, and cognitive performance of patients with relapsing-remitting multiple sclerosis.
    Trenova AG; Slavov GS; Draganova-Filipova MN; Mateva NG; Manova MG; Miteva LD; Stanilova SA
    Neurol Res; 2018 Mar; 40(3):153-159. PubMed ID: 29297273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP
    Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indices of cognitive dysfunction in relapsing-remitting multiple sclerosis: intra-individual variability, processing speed, and attention network efficiency.
    Wojtowicz M; Omisade A; Fisk JD
    J Int Neuropsychol Soc; 2013 May; 19(5):551-8. PubMed ID: 23425598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theory of mind and empathy in patients at an early stage of relapsing remitting multiple sclerosis.
    Kraemer M; Herold M; Uekermann J; Kis B; Wiltfang J; Daum I; Dziobek I; Berlit P; Diehl RR; Abdel-Hamid M
    Clin Neurol Neurosurg; 2013 Jul; 115(7):1016-22. PubMed ID: 23199520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specificity of attention and cognitive inhibition processes in relapsing -remitting multiple sclerosis patients with consideration of their mood level].
    Tyburski E; Potemkowski A; Cheć M; Sołtys A; Mak M; Samochowiec A
    Psychiatr Pol; 2014; 48(2):307-18. PubMed ID: 25016768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.